Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 4 of 18 for:    "Chromosomal Disease" | "Mercaptopurine"

Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03007147
Recruitment Status : Recruiting
First Posted : January 2, 2017
Last Update Posted : November 18, 2019
Sponsor:
Collaborators:
National Cancer Institute (NCI)
University of Milano Bicocca
Information provided by (Responsible Party):
Children's Oncology Group

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : June 30, 2028
Estimated Study Completion Date : June 30, 2028